Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 28Colonic Neoplasms 19Rectal Neoplasms 17Neoplasm Metastasis 16Cholangiocarcinoma 10Stomach Neoplasms 9Neoplasms 4Liver Neoplasms 4Carcinoma, Hepatocellular 4Esophageal Neoplasms 3Pancreatic Neoplasms 2Gastrointestinal Stromal Tumors 2Cirrhosis, Familial, with Pulmonary Hypertension 2Bile Duct Neoplasms 2Appendiceal Neoplasms 2Adenocarcinoma Of Esophagus 2Vipoma 1Stage IV Fallopian Tube Cancer AJCC v6 and v7 1Somatostatinoma 1Resected Liver Metastases From Colorectal Cancer 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Unknown Primary 1Nasopharyngeal Carcinoma 1Insulinoma 1Hyperthermia 1Glucagonoma 1Genetic Diseases, Inborn 1

Interventions

Gemcitabine 15130-nm albumin-bound paclitaxel 10Albumin-Bound Paclitaxel 7Oxaliplatin 5Paclitaxel 4Leucovorin 4Fluorouracil 4Carboplatin 4Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2napabucasin 2Pemetrexed 2PEGPH20 2MK-4721 2Irinotecan 2tremelimumab 1selinexor 1relacorilant 1ponatinib 1neratinib 1irinotecan sucrosofate 1folfirinox 1ensituximab 1durvalumab 1contrast agent BR1 1cobimetinib 1ceritinib 1cc-486 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Pancreatic Ductal × Floxuridine × Clear all
NCT03856658 2025-06-17

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Corewell Health West

Phase 2 Active not recruiting
14 enrolled
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡